A Day of Healthcare Innovation in partnership with Doceree
Doceree participated in SXSW 2025 held in Austin, Texas from March 7 to March 15, 2015.
On the very first day of SXSW 2025, Doceree hosted the 'Future of Health Day' event in collaboration with FINN Partners and Humble Ventures. Discussions were held on a range of topics that included space medicine, bioengineering approaches to organ donation, role of cloud technology in food security, and the future of pharma marketing. Fireside conversations on harnessing real-world patient data and patient-centricity also drew many participants.
Session 1: Bioengineering Approaches to Solve the US Organ Shortage: Carnegie Mellon University College of Engineering
Moderator: Ritesh Patel, Chief Growth Officer, Doceree
Speakers:
- Keith Cook, David Edward Schramm Professor and Head, Biomedical Engineering (CMU)
- Rosalyn Abbott, Associate Professor, Biomedical Engineering (CMU)
- Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering (CMU)
- C. Burcin Taner, M.D., Chair of the Transplant Center at the Mayo Clinic (Florida)
The session began with a focus on the severe organ shortage crisis in the US. The government data reveals that more than 103,223 people are on the national transplant waiting list, with 17 dying each day.
The panel deliberated on the alarming statistic and what needs to be done to solve the crisis. It explored the role of bioengineering in addressing the shortage using ex-vivo organ repair technique, where damaged organs are perfused and treated outside the body to use them for transplantation. Researchers at Carnegie Mellon University and Mayo Clinic have been working on ex-vivo organ repair and 3D bioprinting.
The panel also explored how 3D bioprinting can be used to design functional tissues and organs using living cells, potentially reducing reliance on traditional donors.
Session 2: AI and The Future of Pharma Marketing
Moderator: Kamya Elawadhi, Chief Client Officer, Doceree
Speakers:
- Cozi Namer - VP of Consumer and Clinician Innovation, Pfizer
- Jason Gee, Senior VP, Client Experience at Havas Media
- Jeff McDonald, CEO & Co-Founder at Kythera Labs
The discussion on AI and the future of pharma marketing opened with the panel acknowledging the role of AI in personalized communication for healthcare professionals and enabling data-driven decision-making.
The panel shared insights on how AI-powered analytics can help pharma companies understand HCP behavior and preferences to tailor content for them. Personalizing HCP messages can improve real-time HCP interactions, enhancing engagement and improving brand awareness for pharmaceutical organizations.
AI can process vast amounts of data to identify market trends and suggest insights, enabling precise targeting with contextually relevant messages. AI-driven predictive analytics can help pharmaceutical organizations in other areas as well, such as forecasting sales and demand so that marketers can optimize their strategies effectively.
The panel recognized the role of AI as an integral part of omnichannel marketing, helping pharmaceutical organizations ensure HCP engagement across multiple platforms. One of the most promising roles of AI is in ensuring regulatory compliance by flagging content that is in violation of regulatory standards.